Stocks
Upstream Bio, Inc.UPB
NASDAQHealthcareBiotechnology$2.74
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel therapies for rare and serious diseases, with a focus on metabolic and genetic disorders. Its pipeline includes multiple investigational programs targeting conditions with limited treatment options, and it has attracted investor attention for its potential to address unmet medical needs in niche therapeutic areas.
52W Range: $2.69-$33.68
Congressional Interest in Upstream Bio, Inc. (UPB)
No congressional trades have been disclosed for Upstream Bio, Inc. (UPB) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading UPB?
No congressional trades found for this stock.